Cargando…
(61) Prevalence and Determinants of Cellular Immunity Against Sars-Cov-2 in Heart Transplant Recipients: A Cross-Sectional Study
PURPOSE: Serology studies provide limited information on immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This cross-sectional study aimed to assess prevalence and determinants of anti-SARS-CoV-2 cellular immunity in a cohort of heart transplant (HT) recipients. METHODS...
Autores principales: | Flament, H., Ahmed, M. Ben, Kfoury, C., Ferré, V., Para, M., Melo, V. Da Silva, Charpentier, C., Houhou-Fidouh, N., Vicaut, E., Descamps, D., Dorent, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068053/ http://dx.doi.org/10.1016/j.healun.2023.02.077 |
Ejemplares similares
-
Humoral Response to SARS-CoV-2 mRNA Vaccine in Heart Transplant Recipients up to 4 Months After the Third Vaccine Injection
por: Ferré, V.M., et al.
Publicado: (2022) -
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients
por: Hazan, Fanny, et al.
Publicado: (2023) -
Death Rate in Heart Transplant Recipients during the COVID-19 Outbreak in France
por: Legeai, C., et al.
Publicado: (2021) -
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
por: Gounant, Valérie, et al.
Publicado: (2022) -
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)